Get to know our Speakers

Aid Atlić

PhD in Biotechnology and Biochemical Engineering, Senior Scientist Process Development, VALIDOGEN (Austria)

Aid Atlić got his education at Graz University of Technology. After obtaining his PhD, he joined the team of VALIDOGEN (formerly VTU Technology) in 2011 as research scientist. He is involved in development of recombinant protein production technology with focus on molecular biology and microbial fermentation. The continuous development of the Pichia expression platform within the global technology collaboration with Boehringer Ingelheim, fermentation process development and optimization as well as technology transfer to customers and CMOs and support for implementation of industrial-scale protein production processes are Aid’s main tasks/responsibilities at VALIDOGEN.

Alessandro Cataldo

Sr. Engineer, Digital Lab & Sustainable CMC, Takeda (Austria)

Between 2011 and 2015 Alessandro made his Bachelor degree in the field of engineering and business administration in Munich. In 2015 he moved to Vienna for a dual study in the field of bioprocess engineering, while being part of the working group of Alois Jungbauer. In 2018, Alessandro started his PhD in the same working group focusing on the ecological analysis of clean water for biopharmaceutical production. He finished his PhD in 2021 and joined Takeda. In his current job as Sr. Engineer – Digital Lab he elaborates digital innovation to design sustainable solutions for R&D.

Patrizia Cinelli

Associate Professor at Pisa University, RECOVER project

Partrizia Cinelli is associate professor of Pisa University for applied chemistry and Materials Technology at Master Degree student of Construction Engineering and Architecture at Pisa University, and master degree students of Materials and Nanotechnology. She was researcher at Inter University Consortium of Materials Science and Technology, and then researcher at National Research Council (CNR), Institute for the Physical and Chemical processes (IPCF) unit of Pisa.
She graduated in Chemistry at the University of Florence, and then achieved a PhD in Chemistry at Pisa University partly performed at the United States Department of Agriculture (USDA), Peoria, IL, USA. 20 years of experience in materials science, polymer processing and characterization, biodegradation and life cycle assessment. She is co-author of over 70 papers in peer-reviewed journal, 9 book chapters, and 8 patents on innovative materials, with a scopus h-index of 25, and 2102 citations. She has worked in over 15 EC project from FP5, FP6, FP7 and Horizon 2020, directly following writing, scientific activity, and reporting. She is currently coordinator of the Horizon2020 project ECOAT GA 837863 BBI.2018.SO3.R9 started the 1st May 2019.

Che J. Connon

Professor of Tissue Engineering and Director of Business Development at Newcastle University (United Kingdom)
Co-founder and CEO of 3D Bio-Tissues Ltd (United Kingdom)
Co-founder and CTO of CellulaREvolution Ltd (United Kingdom)

As Professor of Tissue Engineering Che and his team have been putting their minds to solving complex issues in cell and tissue engineering and bioprocessing, often by taking radical approaches.
For example solving critical cell therapy logistical problems by developing a room temperature storage solution (Atelerix Ltd); within bioprocessing realising that the limits to getting bioreactors to produce large numbers of cells was not a surface area problem but a cell collection problem (CellulaREvolution Ltd) and finally a novel process to engineer complex tissue structures (3D Bio-Tissues Ltd).

Lixin Dai

Senior Director of Biotechnology, Modern Meadow Inc. (USA)

Lixin Dai is the Senior Director of Biotechnology at Modern Meadow Inc. Lixin holds a PhD degree in Cellular, Molecular, and Microbial Biology and did postdoc training in Jef Boeke’s lab at Johns Hopkins University School of Medicine.
Lixin developed Modern Meadow’s recombinant collagen production platform and oversees biotech function including strain engineering, fermentation, downstream processing and analytics. Lixin was an integral part of the launch of Bio-TexTM, Modern Meadow’s first biofabricated materials and the launch of the first beauty product Bio-Coll@genTM.

Heleen De Wever

Project Manager Biotechnology, VITO, the Flemish Institute for Technological Research (Belgium)

Heleen De Wever holds a PhD in Applied Biological Sciences. Since 2001, she works as a project manager at VITO, the Flemish Institute for Technological Research. Her research focuses on 2 main topics. A first one is bioprocess intensification, which can often be achieved by integrating membrane technology with microbial and enzymatic conversions. A second topic is gas fermentations on C1 feedstocks, including CO2 and methanol. In the area of valorization of CO2-rich off-gases, Heleen coordinated among others the recently finished Horizon2020 project BioRECO2VER.

Antonio Dobon Lopez

Area Manager of Recycling Technologies and Valorisation at ITENE (Spain)

He holds a MSc Environmental Nanotechnology by the University of Zaragoza (Spain) with Outstanding Award of Masters Degree with Distinction. He also holds a Chemical Engineering Degree by the Polytechnic University of Valencia (Spain). Currently working as Area Manager of Recycling Technologies and Valorisation at ITENE (Packaging, Transport and Logistics Research Center) and he was formerly Technical Director and LCA project manager at ITENE too. He has also a wide experience of 17-years in LCA, carbon footprint, ecodesign, ecoefficiency, recycling, waste management and nanotechnology. Member of the Spanish LCA network and the Spanish Standardization Technical Committee AEN/CTN 150 on environmental management, and critical reviewer of LCA studies. He is also accredited independent verifier of Environmental Product Declarations under the Environdec® EPD scheme. He has published more than 18 indexed papers in the International Journal of Life Cycle Assessment, Journal of Cleaner Production and Packaging Technology and Science journal.

Elke Duwenig

Senior Biotechnology Expert Global Regulatory / Public & Government Affairs, Nutrition & Health at BASF SE

Elke Duwenig is passionate for innovation & sustainability and for safeguarding biotech products and opening markets.
Elke is senior expert in biotechnology and active in Regulatory and Government Affairs in Nutrition&Health. Next to supporting strategies, R&D projects and sales products, she is engaged in legislations and authority work, both in the EU and globally.
Previously, Elke has been responsible for the political work at BASF Plant Science and worked for 10 years as Head of Research Plant Biotechnology on new biotech products. Engaged in authority work. Active in R&D projects like healthy fatty acids in rapeseed, high yielding rice, fungal-resistant potato and herbicide resistant soybean as well as molecular enabling tools.
Elke studied biology and chemistry at University Münster, Germany and Stanford University, USA. Graduated in molecular plant physiology at the IGF in Berlin and completed two postdocs at MPI in Golm and University of Freiburg, Germany, before joining BASF.

Philippe-Alexandre Gilbert

Senior Program Officer, CMC at Bill & Melinda Gates Foundation (USA)

Philippe-Alexandre Gilbert is a Biochemistry graduate of the University of Ottawa. He subsequently received his Master’s degree in Molecular Biology and his Ph.D. in Chemical Engineering at Laval University. For more than 20 years, Philippe has built a solid expertise in bioprocess development for the production of vaccines, gene therapy vectors and oncolytic viruses for cancer therapy. He had the privilege of working for both Academia (Robarts-Schulich in Canada and the Emerging Pathogen Institute at the University of Florida) and the private sector with Sanofi-Pasteur, MedImmune Vaccines, Novartis Vaccines and GSK Vaccines. In both North America and Europe, Philippe led task forces on the development of vaccines for HIV, RSV, CMV, SARS, Influenza and COVID. Philippe, just recently, was responsible for the Flu Technology Group at Sanofi Pasteur for the development of the Next Generation Flu vaccine. He joined the Vaccine Development and Surveillance (VDS) group at the Bill and Melinda Gates Foundation as Senior Program Officer CMC.

Tom Ewing

Research Scientist at Wageningen Food & Biobased Research

Tom Ewing works as a research scientist at Wageningen Food & Biobased Research, an applied research institute that is part of Wageningen University & Research in the Netherlands. His work focusses on the use of enzymatic conversion processes for the production of chemicals from sustainable carbon sources and the application of enzymes for recycling purposes. Prior to joining Wageningen Food & Biobased Research in 2018, he obtained an MSc in Chemical Sciences from Utrecht University and a PhD degree in the field of enzyme (bio)chemistry from Wageningen University.

Mark Goedkoop

Founder of PRé (The Netherlands)

Mark Goedkoop Founded PRé in 1990 as the specialist in Life Cycle Assessment software and Consulting. The SimaPro software is used worldwide and supported by a Partner network in 25 countries. ( Mark is no longer involved in the management of PRé, which gives him room to focus on projects as the ones highlighted below.

Mark has been very active in the development of the EU Environmental Footprint development and contributed to the Taxonomy as an expert. Mark is also responsible for developing widely used environmental impact assessment methodologies, such as ReCiPe, which is also one of the metrics used for the biodiversity assessment for Financials in the Platform for Biodiversity Assessment for Financials ( .

Since 2013, Mark has been facilitating the Social Value Chain Initiative ( This initiative is governed and financed by proactive companies that developed the Handbook for Product Social Impact Assessment under a Creative Commons licence. The companies have tested the handbook in dozens of case studies and developed whitepapers on Portfolio Assessment and Improving Reporting of social impacts. Currently the companies a re working on aligning with the Due Diligence Legislation, Taxonomy and Just transition. The member companies include DSM, BASF, Corbion, Richemont, Fuji Oil (Japan), LG-Chem (Korea) and ArcelorMittal. A new initiative is the Social Value Community, where anyone can join to engage, learn and contribute to the development of this methodology at

Stéphane Guillouet

Professor in Biochemical and Metabolic Engineering at INSA Toulouse (France)

Stéphane Guillouet, Professor at INSA Toulouse, is team leader of the Fermentation Advances and Microbial Engineering group at the Toulouse Biotechnology Institute. He was graduated in Industrial Microbiology at the University of Marseille in 1989. He received his PhD in Biotechnology and Food Industry in 1996 at INPL-Nancy. He then specialized in metabolic engineering at MIT (USA) for 3 years. He is currently developing a research activity at TBI for improving microbial performances within bioreactors through Biochemical and Metabolic Engineering approaches.

Albert Guisasola

Assistant Professor at the Chemical, Biological and Environmental Department at UAB (Spain)

Albert Guisasola i Canudas (1978) is a chemical engineer (UAB, 2001) and PhD in Environmental Technology (UAB, 2005. He is an assistant teacher at UAB and part GENOCOV research group ( Albert is involved in different research lines from modelling novel advanced biological systems to bioelectrochemical hydrogen production or nitrogen recovery from wastewater. He is the PI of the H2020 VIVALDI Project (, participates in the LIFE+ NIMBUS project ( and leads the Spanish FOSPHORUS project aiming at P recovery as both struvite and vivianite.

Falk Harnisch

Professor for Electrobiotechnology at Leipzig University for Electrobiotechnology (Germany)
Group leader at the Helmholtz-Centre for Environmental Research – UFZ (Germany)

Falk Harnisch holds a Full Professorship at Leipzig University for Electrobiotechnology and is a group leader at the Helmholtz-Centre for Environmental Research – UFZ, Germany. He received his PhD from Greifswald University, Germany in 2009 as well as several fellowships and awards and is currently serving as a President of the International Society for Microbial Electrochemistry and Technology (ISMET). His research ranges from fundamentals of microbial electrochemistry via electro-organic synthesis to engineering of microbial electrochemical technologies. He will highlight the grand potential of CO2-based electrobiorefineries.

Rebecca Hochstein

Global Bioprocess Science Specialist at 3M (USA)

Dr. Rebecca Hochstein works in Application Development for the Biopharmaceutical Purification group at 3M, helping to develop innovative bioprocessing solutions in the areas of viral clearance, virus and virus-like-particle purification, and gene therapy using innovative functional fiber chromatography solutions.  She completed her PhD in Microbiology and Immunology at Montana State University and studied viruses in Yellowstone hot springs.

Dirk Holtmann

Professor for the Intensification of Bioprocesses at Technische Hochschule Mittelhessen (Germany)

Dirk Holtmann has completed his diploma in chemical engineering/biotechnology in 1999. He obtained his PhD at the Otto von Guericke University of Magdeburg on the electrochemical measurement of the microbial activities. He is head of the “Intensification of bioprocesses” group at the THM Giessen. His current research activities concentrate on bioreaction engineering, biocatalysis and biotransformation, bioelectrochemical synthesis and CO2 conversion.

Thomas Jakl

Federal Ministry for Climate Action, Environment, Energy, Mobility, Innovation and Technology (Austria)
General Directorate V – Protection of the Environment and Circular Economy

Thomas Jakl is the former chair of the European Chemicals Agency’s (European Chemicals Agency, ECHA) Management board and is Deputy Director General of the Austrian Environment Ministry responsible for Chemicals Policy. His field of activity includes legislation on chemical substances at the national, European and UN levels. He served as ECHA’s president from 2008 until September 2012. He is president of the Governing Board of PARC – the “Partnership for Risk Assessment for Chemicals” a 400 Million Euro initiative of the EU’s research program “Horizon Europe”.

Simone Jährig

National Contact Point for Horizon Europe “Cluster 6 – Food, Bioeconomy, Natural Resources, Agriculture and Environment, (Austria)

Simone studied “Food Sciences and Biotechnology” at the University of Natural Resources and Life Sciences (BOKU) in Vienna and graduated 2015 with a PhD in “Biomolecular Technology of Proteins” from the same University. After a 4 years Postdoctoral fellowship at the University of Georgia (USA), she returned to Austria and started working at the Austrian Research Promotion Agency (FFG). In her role as “National Contact Point” she advises interested Austrian Researchers and companies about EU funding opportunities, especially in the field of Life Sciences. This also includes awareness raising and promotional activities as well as trainings and proposal checks for applicants to increase their changes for funding in this high competitive programme.

David Kaplan

Professor, Biomedical Engineering
Chair, Biomedical Engineering
Stern Family Professorship in Engineering, Biomedical Engineering
Distinguished Professor, Tufts University School of Engineering
Graduate Biomedical Sciences Member, Cell, Molecular and Developmental Biology Program
Distinguished Professor, Biology

David Kaplan is the Stern Family Endowed Professor of Engineering at Tufts University, a Distinguished University Professor, and Professor and Chair of the Department of Biomedical Engineering. His research focus is on biopolymer engineering, tissue engineering, regenerative medicine and cellular agriculture. He has published over 1,000 peer reviewed papers, he is editor-in-chief of ACS Biomaterials Science and Engineering and he serves on many editorial boards and programs for journals and universities. He has received awards for his research and teaching and is an elected Fellow of the American Institute of Medical and Biological Engineering and the National Academy of Engineering.

Miriam Klausberger

Senior Scientist at Institute of Bioprocess Science and Engineering, BOKU (Vienna)

Miriam Klausberger obtained her PhD in Protein biotechnology (“BioToP”) from the University of Natural Resources and Life Sciences (BOKU) in Vienna. After her Post Doc at acib, she currently is Senior scientist in the Laboratory of Reingard Grabherr at the Department of Biotechnology at BOKU and principal investigator of two FWF-funded Coronavirus research collaboration projects together with the Johannes Kepler University, the Medical University and the Austrian Institute of Technology. She has also been co-ordinator of an inter-university consortium of over 100 researchers that was involved in the production of SARS-CoV-2 antigens and the establishment of SARS-CoV-2 antibody tests in the early phase of the pandemic; part of this work will be presented at the conference.

Seren Kell

Science and Technology Manager, Good Food Institute Europe (United Kingdom)

Seren’s background is originally in biochemistry, with a focus on cellular senescence and the fundamental processes underlying human ageing. Over the last few years she has been involved in both the cultivated meat space (focusing on cell culture media, and then co-founding Cellular Agriculture UK), and external innovation more generally – previously working at IN-PART, a startup that connects R&D-focused companies with academia to encourage greater collaboration. Now at the Good Food Institute Europe, Seren works to build a strong, well-funded scientific community in the sustainable proteins (plant-based, cultivated, and fermentation-made meat, eggs, and dairy) space across Europe. Seren’s session will focus on the opportunities and resources available for researchers moving into this space.

Florian Krainer

Process Engineer & Project Development at ZETA GmbH (Austria)

Florian Krainer studied process engineering at the technical university of Graz and is working in the pharmaceutical industry for more than 10 years. Within hist tasks as project developer at ZETA GmbH he is responsible for process transfers, scale up studies and project realizations.
To meet the increasing challenges of the market and the demand for deeper process understanding for new products, he works with an interdisciplinary team on measurement and evaluation methods for industrial bioreactors. This collaboration enables precise predictions and new insights into process parameters depending on equipment design and its operation.

Florian Krammer

Professor of Vaccinology at the Icahn School of Medicine at Mount Sinai (United States)

Florian Krammer, PhD, graduated from the University of Natural Resources and Life Sciences, Vienna (Austria) in 2010. He received his postdoctoral training in the laboratory of Dr. Peter Palese at the Icahn School of Medicine at Mount Sinai, New York working on hemagglutinin stalk-based immunity and universal influenza virus vaccines. In 2014 he became an independent principal investigator and is currently the Mount Sinai Professor of Vaccinology at the Icahn School of Medicine at Mount Sinai. Dr. Krammer’s work focuses on understanding the mechanisms of interactions between antibodies and viral surface glycoproteins and on translating this work into novel, broadly protective vaccines and therapeutics. The main target is influenza virus but he is also working on coronaviruses, flaviviruses, hantaviruses, filoviruses and arenaviruses. He has published more than 300 papers on these topics. Since 2019, Dr. Krammer has served as principal investigator of the Sinai-Emory Multi-Institutional Collaborative Influenza Vaccine Innovation Center (SEM-CIVIC), which develops improved seasonal and universal influenza virus vaccines that induce long-lasting protection against drifted seasonal, zoonotic and future pandemic influenza viruses.

Population immunity to SARS-CoV-2 is currently very heterogeneous and influenced by individual exposure histories to infection, breakthrough (variant) infections and immunization with different vaccines. We have investigated these differences in a large cohort study, the PARIS cohort, in New York City in respect to functional serum and mucosal immune responses to SARS-CoV-2 and its variants. Furthermore, we have developed Newcastle disease virus vectored SARS-CoV-2 vaccines (NDV-HXP-S), which can be manufactured at low cost in embryonated eggs. These vaccine candidates have advanced into phase I and II clinical trials in five countries. Immune responses induced by NDV-HXP-S are comparable with responses after mRNA vaccination in our PARIS cohort.

Sang Yup Lee

Distinguished Professor of Chemical and Biomolecular Engineering, KAIST (Korea)
Vice President for Research, Director of BioProcess Engineering Research Center (Korea)
Director of Bioinformatics Research Center (Korea)

Sang Yup Lee is Distinguished Professor of Chemical and Biomolecular Engineering, KAIST. He is also Vice President for Research, Director of BioProcess Engineering Research Center, and Director of Bioinformatics Research Center. He served as the Founding Dean of College of Life Science and Bioengineering, and also Dean of KAIST Institutes at KAIST. He is fellow of Korean Academy of Science and Technology, National Academy of Engineering Korea, American Academy of Microbiology, American Institute of Medical and Biological Engineering, World Academy of Sciences, National Academy of Inventors, American Association for the Advancement of Science, American Institute of Chemical Engineers, and Society for Industrial Microbiology and Biotechnology. He is also International Member of both National Academy of Sciences and National Academy of Engineering, USA. He has served as a Chairman of the Global Agenda Council on Emerging Technologies, and also the Global Future Council on Biotechnology at World Economic Forum. He received numerous awards including National Science Medal, National Order of Merit-Red Stripes, Samson Prime Minister’s Prize, Eni Award, James Bailey Award, Marvin Johnson Award, HoAm Prize, and POSCO TJ Park Prize, among others. His research interests include metabolic engineering, industrial biotechnology, synthetic biology, and systems biology. He pioneered systems metabolic engineering.

Adrian Leip

Head of Sector Bioeconomy in the European Commission

Since August 2021, Adrian Leip works at the European Commissions’ Directorate General Research & Innovation as Head of Sector – Bioeconomy in the Food Systems and Bioeconomy Unit, coordinating the work on the bioeconomy policies and the implementation and follow-up of the 2018 EU Bioeconomy Strategy and its Action Plan.
Before joining DG RTD, he worked for almost 20 years at the EC-Joint Research Centre in Ispra (Italy). Adrian has authored more than 100 scientific papers on environmental and economic modelling, nutrient cycling, GHG emissions, LCA etc. He is Lead Author of the IPCC, such as the recent IPCC 6th Assessment Report on a ‘food system’ section (2022, Chapter 12). Adrian has a PhD in Geo-ecology, University of Bayreuth, Germany.

Maria Jose Lopez

Associate Professor, RECOVER project

Associate Professor (2002) – She received her PhD (1996) in Pharmacy. Her research is focused on the study of microorganisms that produce lignocellulose-degrading enzymes and the use of microorganisms for bioremediation. She has been the PI of 3 national projects, leader of UAL-team in 3 EU project and 1 USA project. She published 56 scientific papers and 3 patents.

Stefan Lutz

Senior Vice President Research, Codexis, Inc. (United States)

Stefan Lutz joined Codexis in 2020 as the Senior Vice President of Research to lead the company’s research team advancing the discovery of proteins. Previously, he was a Professor and Chair of the Chemistry Department at Emory University, having joined the university in 2002 and ascending to Chemistry Department Chair in 2014. Stefan has co-authored more than 65 articles published in peer- reviewed journals and six technical books and journals. He holds six patents and is a frequent lecturer and speaker. Dr. Lutz received a B.Sc. in chemistry/chemical engineering from the Zurich University of Applied Sciences, an M.Sc. in Biotechnology from the University of Teesside and a Ph.D. in chemistry from the University of Florida. He was a postdoctoral fellow at Pennsylvania State University.

Beatrice Monigli

Biosphere srl, BIZENTE project

Beatrice Mongili is an R&D project specialist at Biosphere, an Italian SME operating in the field of industrial biotechnology. After a master’s degree in industrial biotechnology (2015) at the University of Turin, she held a PhD in chemical engineering at the Polytechnic University of Turin (2020) (Turin, IT). There, she developed a research line based on polyhydroxyalkanoate production via gas fermentation. During this period, she collaborated with CISIC-CIB (Polymer Biotechnology Group, Madrid, SP) and was a visiting student at the Pontifical Catholic University (School of Biochemical Engineering, Valparaiso, CL). In Biosphere, she is involved in the development of lab-scale projects, carrying on research activities for national and EU-funded projects (BIZENTE, PRIME) and contract R&D services.

Bernt Nilsson

Professor at Department of Chemical Engineering, Lund University (Sweden)
Director at Process Industry Centre at Lund University, PIC-LU (Sweden)

Bernt´s main research interest is modelling, optimization, automation and control of process systems, particular downstream processing of biologics. The talk presents a novel continuous bioprocess for antibody production, its design principle and optimization. The process is implemented, automated and validated in both lab- and pilot-scale.

Angelo Nuzzo

National Contact Point for Horizon Europe “European Innovation Council” (EIC)

More Information coming soon …

David O'Connell

Associate Professor, School of Biomolecular & Biomedical Science, University College Dublin (Ireland)

I am a biochemist with a deep interest in molecular biology. I study calcium binding proteins and develop methods for protein engineering, proteomic analysis and development of protein array technologies. I express proteins in E.coli & Yeast cells, HEK293 & CHO cells, which demands a lot of protocol development. I am highly collaborative and with a newly invented phage display platform for a small, stable protein scaffold I look forward to discussing and starting new collaborations at this meeting. In my talk I will present details of protocols we have developed for the purification of new inhibitors we have selected from this platform.

Mark Post

Professor of Sustainable Industrial Tissue Engineering at Maastricht University (The Netherlands)
CSO & Co-Founder Mosa Meat (The Netherlands)
CSO & Co-Founder Qorium (The Netherlands)

Mark Post is an MD, PhD and professor of Sustainable Industrial Tissue Engineering at Maastricht University. His main research includes engineering of tissues for medical applications and consumer products, which has led to the development of cultured beef from bovine skeletal muscle stem cells. In August 2013, he presented the world’s first hamburger from cultured beef. He is CSO and co-founder of two companies, MosaMeat and Qorium that will commercialize cultured meat and cultured leather.cale.

Bernhard Sissolak

Head of Innovation Pharma

Bernhard Sissolak has worked for more than 7 years in the field of Bio-Process Engineering, cell culture processing and implementation of Process Analytical Technologies where part of his daily life. In 2019, he started to work at Bilfinger Life Science where he launched together with BOKU, Vienna the ambitious end2end project, with the focus on constructing and design a truly continuous process skid. Since April 2022, he is leading the Innovation Management Department (section Pharma). Now, he is chasing after future market trends and is implementing novel technologies at Bilfinger Life Science.

Peter Stogios

Senior Research Associate, BioZone, Dept. of Chemical Engineering and Applied Chemistry, University of Toronto (Canada)

Peter Stogios obtained his PhD from the Ontario Cancer Institute in structural biology. He currently works at BioZone at the University of Toronto where he studies enzyme discovery and engineering, mechanisms of antimicrobial resistance, and antimicrobial drug discovery. He was attracted to the field of cellular agriculture as it has the potential to be transformative in addressing the climate crisis, the fact that is accommodates researchers from many disciplines, and that he could utilize his experience in protein structural biology to solve one of the most important issues in the industry (growth factors).

Andrew J. Stout

PhD candidate at Tufts University (United States)

Andrew Stout is a PhD candidate and New Harvest fellow in Dr. David Kaplan’s Biomedical engineering lab at Tufts University. At Tufts, Andrew studies media development for cultured meat, as well as genetic strategies to enhance cultured meat products and processes. Prior to Tufts, Andrew obtained a degree in Materials Science from Rice University, and has worked in the field of Cellular Agriculture as a student researcher in Dr. Mark Post’s cultured meat lab, as well as a research associate on the strain engineering team at Geltor, Inc., in San Francisco

Gregor Tegl

Co-founder & CEO of Arkeon Bio (Austria)

Gregor has 10+ years of experience in biochemistry and biotechnology and is on a steady quest for new technologies that have the potential to revolutionize the way we’re utilizing the natural resources of our planet.
After obtaining his PhD at the University of Natural Resources and Life Sciences Vienna, he continued his dedication for environmental biotechnology at the University of British Columbia Vancouver, Canada, researching the use of enzymes as green catalysts to replace toxic chemicals for the synthesis of biomolecules.
His passion for food and sustainable eating ignited a 5+ year long journey of exploring microbes to produce next-generation nutrients and food ingredients. Gregor’s scientific expedition resulted in an entirely new method of producing alternative proteins using CO2 – without the need for any agricultural inputs, changing agriculture the way we know it.

Lieven Thorrez

Professor at KU Leuven (The Netherlands)

Lieven Thorrez has a multidisciplinary background in biomedical sciences, representing over two decades of experience with animal cell cultures, including the development of viral vectors for targeted gene delivery, stem cell biology, muscle tissue engineering, applied bioinformatics, systems biology, and evolutionary biology. His current research deals with cell isolation, expansion, and characterization, the engineering of a blood vessel network in muscle, methods for muscle stimulation, and de- and recellularization methods towards applications (drug testing, regenerative medicine and cultured meat production). His laboratory is involved in national and European projects and collaborates with industry, offering tools for drug testing and consulting services.

Marco van den Berg

Principal Scientist Food and Application, DSM (The Netherlands)

Marco is Principal Scientist for Food & Application at the Center for Food Innovation of DSM Food & Beverage, with 25+ years’ experience in the field of Industrial Biotechnology, including enzyme screening, strain development, antibiotics and proteins. Covering the identification, development and application of ingredients in industrial processes, currently focusing on the fields of alternative proteins, savory and sugar reduction. His focus is triggered by unmet customer/consumer needs, driving the ambition to identify limitations of current processes and opportunities for new processes. He has published over 70 peer-reviewed papers and this led to a similar number of patent applications. He participates(d) in various national and international Public Private Partnerships, some covering more fundamental and some more applied research questions.

Julio Vidal

University of Zaragoza, AITIIP, BIZENTE Project

Julio is a chemist by the university of Zaragoza with a master in nanomaterials. He is currently working on his PhD in advanced biomaterials and their end of life while working on AITIIP where he has been developing his research activities for more than 5 years. In this time, he has worked bringing together investors and innovators as well as boosting and financing circular economy projects. Among the projects in which Julio has participated, it is possible to find different topics related to circular economy and composites, for example some covering waste to added value products, improvement of the efficiency in the manufacture process and enhancement of the packaging environmental perform through eco-design.

Andreas Wagner

Head, Liposome Technology at Polymun Scientific GmbH (Austria)

Andreas has significant expertise in incorporation and optimization of hydrophilic, lipophilic and amphipatic substances into liposomes and LNPs and development for clinical use. He studied Biotechnology in Vienna, Austria and earned his Master and Ph.D. degrees in the field of biopharmaceutical technology/ liposomology at the Institute of Applied Microbiology supervised by Prof. Hermann Katinger. Dr Andreas Wagner is listed as inventor on several patents, like the liposome technology and some product patents of liposomal formulations. Furthermore, he has published several peer reviewed articles dealing with liposomes, the technology, products thereof and their application in preclinical and clinical studies.
During the early days of the Covid-19 pandemic, industry partners reached out to Polymun to set up production processes for mRNA-LNPs together with the respective analytical test methods. Within weeks, a robust and scalable process has been developed, process conditions have been optimized and the process has been adapted to meet requirements for industrial scale. The LNP production process has to meet several requirements, such as simplicity, robustness, potential to scale up and easy handling. Data will be presented, which describe hurdles and solutions throughout these processes.

Matthew Watson

Principal Scientist in the Vaccine Process Development Department at Merck Sharpe and Dohme (United States)

Matthew Watson is a Principal Scientist in the Vaccine Process Development department at Merck Sharpe and Dohme. In a career spanning more than 25 years, he has worked on numerous vaccine and biologic projects, spanning several modalities. These include proteins, conjugates, and live viruses. He currently leads development of scalable purification processes for vaccine candidates to supply clinical studies and bridge the gap from discovery to manufacturing. Matthew will present on Merck’s live virus vaccine efforts, focusing on development of their Dengue virus vaccine candidate.